Nina R Schooler Selected Research

Nina R Schooler Research Topics

Disease

46	Schizophrenia (Dementia Praecox) 05/2022 - 01/2002
19	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 07/2003
5	Treatment-Resistant Schizophrenia 01/2020 - 01/2002
4	Weight Gain 05/2012 - 08/2004
3	Headache (Headaches) 03/2015 - 05/2010
3	Mental Disorders (Mental Disorder) 12/2014 - 11/2007
2	Hallucinations (Hallucination) 01/2020 - 10/2005
2	Dyslipidemias (Dyslipidemia) 12/2014 - 09/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2014 - 09/2006
2	Cognitive Dysfunction 08/2013 - 10/2007
2	Obesity 09/2006 - 08/2004
2	Tardive Dyskinesia 08/2004 - 01/2002
1	Syndrome (Syndromes) 05/2016
1	Tachycardia (Tachyarrhythmias) 05/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2015
1	Nasopharyngitis 03/2015
1	Hypertension (High Blood Pressure) 12/2014
1	Prediabetic State (Prediabetes) 12/2014
1	Insulin Resistance 12/2014
1	Prehypertension 12/2014
1	Overweight 12/2014
1	Abdominal Pain (Pain, Abdominal) 08/2013
1	Tremor (Tremors) 05/2010
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2009
1	Chronic Disease (Chronic Diseases) 04/2009
1	Substance-Related Disorders (Drug Abuse) 11/2007
1	Hyperglycemia 09/2006
1	Fatigue 07/2005
1	Cataract (Cataracts) 08/2004
1	Myocarditis (Carditis) 08/2004
1	Hyperlipidemias (Hyperlipidemia) 08/2004
1	Psychomotor Agitation (Akathisia) 08/2004
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2004
1	Major Depressive Disorder (Major Depressive Disorders) 04/2004
1	Movement Disorders (Movement Disorder) 01/2003

Drug/Important Bio-Agent (IBA)

27	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2002
11	Clozapine (Clozaril)FDA LinkGeneric 01/2020 - 01/2002
10	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 02/2004
3	Paliperidone Palmitate FDA Link 01/2018 - 05/2010
3	Olanzapine (Zyprexa)FDA Link 12/2014 - 12/2006
3	Galantamine (Galanthamine)FDA LinkGeneric 08/2013 - 01/2008
2	Polytetrafluoroethylene (Teflon)FDA Link 01/2017 - 01/2016
2	Antidepressive Agents (Antidepressants)IBA 03/2015 - 02/2005
2	alpha7 Nicotinic Acetylcholine ReceptorIBA 08/2013 - 02/2008
2	Cytidine Diphosphate Choline (Citicoline)IBA 08/2013 - 02/2008
2	Pharmaceutical PreparationsIBA 03/2013 - 05/2010
2	ProlactinIBA 05/2012 - 08/2004
2	4,4',5'-trimethylazapsoralenIBA 11/2007 - 04/2004
2	ziprasidone (Geodon)FDA Link 08/2004 - 04/2004
1	Dihydrotachysterol (AT 10)IBA 05/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Insulin (Novolin)FDA Link 12/2014
1	Quetiapine Fumarate (Seroquel)FDA Link 12/2014
1	Triglycerides (Triacylglycerol)IBA 12/2014
1	Hemoglobins (Hemoglobin)IBA 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	PlacebosIBA 08/2013
1	haloperidol decanoate FDA LinkGeneric 05/2012
1	fluphenazine depot (modecate)FDA LinkGeneric 05/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 12/2009
1	Ligand-Gated Ion ChannelsIBA 02/2008
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2008
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2008
1	Nicotinic AgonistsIBA 01/2008
1	CytidineIBA 01/2008
1	N-Methylaspartate (NMDA)IBA 10/2007
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 10/2007
1	Cycloserine (Seromycin)FDA Link 10/2007
1	Excitatory Amino Acid AgentsIBA 10/2007
1	LipidsIBA 09/2006
1	Modafinil (Provigil)FDA Link 07/2005
1	Thioridazine (Mellaril)FDA LinkGeneric 08/2004
1	Mesoridazine (Serentil)FDA Link 08/2004
1	Aripiprazole (Abilify)FDA Link 04/2004
1	Haloperidol (Haldol)FDA LinkGeneric 05/2002

Therapy/Procedure

10	Injections 12/2020 - 10/2009
8	Secondary Prevention 05/2022 - 01/2003
3	Therapeutics 03/2015 - 07/2005
2	Patient Readmission 05/2022 - 04/2016
2	Time-to-Treatment 05/2016 - 10/2005
2	Aftercare (After-Treatment) 10/2007 - 02/2005
2	Drug Therapy (Chemotherapy) 01/2006 - 01/2002
1	Role Playing (Playing, Role) 01/2019
1	Combined Modality Therapy 03/2015
1	Duration of Therapy 12/2014
1	Microspheres (Microsphere) 05/2012
1	Polypharmacy 07/2011